Skip to content

Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants

Effect of a High Density Formula on Growth and Safety in Early Postoperative Infants With Congenital Heart Disease Duration of Cardiac Intensive Care Unit(CCU)Stay: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02389491
Acronym
CHD
Enrollment
64
Registered
2015-03-17
Start date
2015-03-31
Completion date
2015-10-31
Last updated
2015-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Keywords

high density formula, heart defects, infant

Brief summary

The purpose of this study is to explore the effects of high density formula in early postoperative infants with congenital heart disease and to assess its safety.

Detailed description

The number of infants born with CHD increases every year and most CHD infants are suffered with malnutrition.Recent studies have shown that increasing energy intake in CHD infants can improve their nutrition status.But there are no high qualified evidences supporting that high density formula can promote infants' nutrition status and ensure its safety. The hypothesis of the current study is that high density formula intake can increase infants'weight and it's safe. The current study adopts randomized,controlled intervention trial, gives high density formula(Infatrini,100kcal/100ml)to CHD infants in intervention group and normal density formula(Neocate,67kcal/100ml)in control group. Intervention begins when infants start enteral nutrition after operation and continues for 7days.

Interventions

DIETARY_SUPPLEMENTnormal density formula (Necocate)

In control group,there are 32 infants

DIETARY_SUPPLEMENThigh density formula(Infatrini)

In intervention group,there are 32 infants

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 12 Months
Healthy volunteers
No

Inclusion criteria

1. diagnosis of congenital heart disease from symptoms, signs, ultrasonic and imaging examination 2. aged from 1 day to 12 months 3. accept extracorporeal circulation open-heart surgery 4. family members voluntarily participate in this study

Exclusion criteria

1. patients have other diseases which cause nutrition disorders, such as gastrointestinal malformation, preoperative gastroesophageal reflux, genetic diseases related to the growth restriction 2. accept total parenteral nutrition 3. predicted the length of CCU stay is less than five days 4. patients have abdominal distention, diarrhea, vomiting

Design outcomes

Primary

MeasureTime frameDescription
weight gain at the 7th day (g)from the first day starting enteric feeding to the 7th daysthe 7th day body weight minus baseline body weight
the number of participants with feeding intolerancefrom the first day starting enteric feeding to the 7th dayFeeding intolerance means participants have gastric retention, vomiting, diarrhea ect. lead to enteric feeding was stopped.

Secondary

MeasureTime frameDescription
Duration of mechanical ventilationparticipants will be followed for the duration of hospital stay, an expected average of 4 weeksevaluate the long term effect of feeding high density formula
length of Cardiac Intensive Care Unit(CCU) stayparticipants will be followed for the duration of hospital stay, an expected average of 4 weeksevaluate the long term effect of feeding high density formula
the number of participants with poor wound healingparticipants will be followed for the duration of hospital stay, an expected average of 4 weeksevaluate the long term effect of feeding high density formula
the number of participants with necrotizing enterocolitisparticipants will be followed for the duration of hospital stay, an expected average of 4 weeksevaluate the long term effect of feeding high density formula

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026